1. Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma. Keiron Dunleave, MD, et al. (2013)
  2. NIH trial shows promising results in treating a lymphoma in young people. NCI Press Release. (2013)
  3. Primary Mediastinal Large B-Cell Lymphoma (PMBL) Outcome May Be Significantly Improved by the Addition of Rituximab to Dose-Adjusted (DA)-EPOCH and Obviates the Need for Radiation: Results from a Prospective Study of 44 Patients. Kieron Dunleavy, MD, et al. (2006)
  4. Primary Mediastinal Large B-Cell Lymphoma. Kerry J. Savage, MD, et al. (2006)
  5. Dose-adjusted EPOCH Chemotherapy for Untreated Large B-Cell Lymphomas: A Pharmacodynamic Approach With High Efficacy. Wyndham Wilson, MD, et al. (2001)


  1. Are there two or more people in your family who have or had lymphoma? Participate in this Harvard Study investigating genetic factors that lead to lymphoma.


  1. Israeli researchers discover compound to protect female cancer patients’ eggs. Evan, Dan. Haaretz. (May 16, 2013).
  2. Parenthood in longtime survivors after EPOCH. Meissner, Julia, MD. 54 ASH Annual Meeting and Exposition. (2012)


  1. Leukemia & Lymphoma Society Co-Pay Assistance Program
  2. First Descents
  3. Camp Koru
  4. Non-Hodgkins Lymphoma Primary Mediastinal Large B Cell Lymphoma Facebook page


  1. Stronger – Cancer music video
  2. Look Good…Feel Better Program